KEGG   DRUG: Irbesartan and hydrochlorothiazide
Entry
D10249            Mixture   Drug                                   
Name
Irbesartan and hydrochlorothiazide;
Avalide (TN);
Ifirmacombi (TN)
Product
  Generic
Component
Hydrochlorothiazide [DR:D00340], Irbesartan [DR:D00523]
Class
Cardiovascular agent
 DG01925  Renin-angiotensin system inhibitor
 DG03231  Antihypertensive
Remark
ATC code: C09DA04
Product: D10249<US>
Efficacy
Antihypertensive
  Disease
Hypertension [DS:H01633]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 C CARDIOVASCULAR SYSTEM
  C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
   C09D ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS
    C09DA Angiotensin II receptor blockers (ARBs) and diuretics
     C09DA04 Irbesartan and diuretics
      D10249  Irbesartan and hydrochlorothiazide <US>
USP drug classification [BR:br08302]
 Cardiovascular Agents
  Cardiovascular Agents, Combinations
   Hydrochlorothiazide/ Irbesartan
    D10249  Irbesartan and hydrochlorothiazide
Drug groups [BR:br08330]
 Cardiovascular agent
  DG01925  Renin-angiotensin system inhibitor
   D10249  Irbesartan and hydrochlorothiazide
  DG03231  Antihypertensive
   D10249  Irbesartan and hydrochlorothiazide
Drug classes [BR:br08332]
 Cardiovascular agent
  DG03231  Antihypertensive
   D10249  Irbesartan and hydrochlorothiazide
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10249
Other DBs
PubChem: 163312280
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system